microdosing glp-1 benefits medications has become a growing topic online. Some people hope a lower dose will reduce side effects, lower costs or quiet food noise without major weight loss. But lower dose Microdosing GLP-1s: Does It Work?
Description
Longer-term concerns include a potential increased risk of pancreatitis, bowel obstruction, and thyroid cancer

Willow did not respond to requests seeking comment about its marketing
Additionally, there is no approved oral formulation to compound from

These findings, revealed more than a decade after the first approval of twice-daily exenatide in 2005, have rekindled enthusiasm for the use of GLP-1R agonists, alone or in combination, in the treatment of T2D and obesity, most compellingly in subjects at high risk for cardiovascular disease
doi: 10.1186/s13048-022-01058-1 115 WangCLiZLiuYYuanL
